Aptamer Development for SARS-CoV-2 and Omicron Variants Using the Spike Protein Receptor Binding Domain as a Potential Diagnostic Tool and Therapeutic Agent. - Shekar PV; Kumar A; Mulgaonkar N; Kashyap S; Choudhir G; Fernando S; Rustgi S (Biomolecules, 2025)